CA3054690A1 - Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes - Google Patents
Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes Download PDFInfo
- Publication number
- CA3054690A1 CA3054690A1 CA3054690A CA3054690A CA3054690A1 CA 3054690 A1 CA3054690 A1 CA 3054690A1 CA 3054690 A CA3054690 A CA 3054690A CA 3054690 A CA3054690 A CA 3054690A CA 3054690 A1 CA3054690 A1 CA 3054690A1
- Authority
- CA
- Canada
- Prior art keywords
- purified
- cannabinoid
- terpene
- alpha
- thc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (35)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762465688P | 2017-03-01 | 2017-03-01 | |
US62/465,688 | 2017-03-01 | ||
US201762469415P | 2017-03-09 | 2017-03-09 | |
US62/469,415 | 2017-03-09 | ||
US201762475153P | 2017-03-22 | 2017-03-22 | |
US62/475,153 | 2017-03-22 | ||
US201762477990P | 2017-03-28 | 2017-03-28 | |
US62/477,990 | 2017-03-28 | ||
US201762489360P | 2017-04-24 | 2017-04-24 | |
US62/489,360 | 2017-04-24 | ||
US201762490567P | 2017-04-26 | 2017-04-26 | |
US201762490465P | 2017-04-26 | 2017-04-26 | |
US62/490,567 | 2017-04-26 | ||
US62/490,465 | 2017-04-26 | ||
US201762491175P | 2017-04-27 | 2017-04-27 | |
US201762491160P | 2017-04-27 | 2017-04-27 | |
US62/491,160 | 2017-04-27 | ||
US62/491,175 | 2017-04-27 | ||
US201762491980P | 2017-04-28 | 2017-04-28 | |
US201762491899P | 2017-04-28 | 2017-04-28 | |
US62/491,899 | 2017-04-28 | ||
US62/491,980 | 2017-04-28 | ||
US201762509651P | 2017-05-22 | 2017-05-22 | |
US62/509,651 | 2017-05-22 | ||
US201762510229P | 2017-05-23 | 2017-05-23 | |
US62/510,229 | 2017-05-23 | ||
US201762510660P | 2017-05-24 | 2017-05-24 | |
US201762510672P | 2017-05-24 | 2017-05-24 | |
US62/510,660 | 2017-05-24 | ||
US62/510,672 | 2017-05-24 | ||
US201762511218P | 2017-05-25 | 2017-05-25 | |
US62/511,218 | 2017-05-25 | ||
US15/616,874 | 2017-06-07 | ||
US15/616,874 US20170266153A1 (en) | 2015-02-27 | 2017-06-07 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
PCT/US2018/020440 WO2018160827A1 (en) | 2017-03-01 | 2018-03-01 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3054690A1 true CA3054690A1 (en) | 2018-09-07 |
Family
ID=63370542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3054690A Pending CA3054690A1 (en) | 2017-03-01 | 2018-03-01 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3589129A4 (es) |
CN (1) | CN110582206A (es) |
AU (1) | AU2018227544A1 (es) |
BR (1) | BR112019018088A2 (es) |
CA (1) | CA3054690A1 (es) |
CO (1) | CO2019009413A2 (es) |
IL (1) | IL268929A (es) |
MX (1) | MX2019010370A (es) |
PE (1) | PE20200383A1 (es) |
WO (1) | WO2018160827A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019147690A1 (en) | 2018-01-23 | 2019-08-01 | High Sierra Technologies, Inc. | Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons |
IL266151A (en) * | 2019-04-18 | 2019-07-31 | Kanabo Res Ltd | Dilute for the cannabinoid preparations |
WO2021012044A1 (en) | 2019-07-22 | 2021-01-28 | Canopy Growth Corporation | Continuous crystallization of cannabinoids in a stirred-tank reactor |
CA3159289A1 (en) * | 2019-11-26 | 2021-06-03 | Lycored Ltd. | Cannabinoid and lycopene anti-inflammatory synergistic combinations |
CA3181384A1 (en) * | 2020-04-29 | 2021-11-04 | Ligar Limited Partnership | Imprinted polymers and methods for their use |
EP4188915A1 (en) * | 2020-07-27 | 2023-06-07 | Canopy Growth Corporation | Methods of synthesizing cannabielsoin and analogs thereof |
WO2022165165A1 (en) * | 2021-01-29 | 2022-08-04 | The Johns Hopkins University | Limonene effects on tetrahydrocannabinol (thc)-induced anxiety |
CN113368086B (zh) * | 2021-08-11 | 2021-12-03 | 龙麻(上海)医药研发有限责任公司 | 一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用 |
WO2023245185A1 (en) * | 2022-06-17 | 2023-12-21 | New Growth Brands, Inc. | Compositions comprising cannabinoids and methods of preparation and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009019322A1 (de) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
TWI583374B (zh) * | 2010-03-30 | 2017-05-21 | Gw伐瑪有限公司 | 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途 |
WO2015074137A1 (en) * | 2013-11-20 | 2015-05-28 | Mary Lynch | Compositions and methods for treatment of ocular inflammation and pain |
BR112017018316A2 (pt) * | 2015-02-27 | 2018-04-17 | Ebbu Llc | composições compreendendo combinações de canabinoides purificados, com pelo menos um flavonoide, terpeno ou mineral |
-
2018
- 2018-03-01 MX MX2019010370A patent/MX2019010370A/es unknown
- 2018-03-01 BR BR112019018088-5A patent/BR112019018088A2/pt not_active Application Discontinuation
- 2018-03-01 PE PE2019001790A patent/PE20200383A1/es unknown
- 2018-03-01 WO PCT/US2018/020440 patent/WO2018160827A1/en unknown
- 2018-03-01 EP EP18760302.2A patent/EP3589129A4/en not_active Withdrawn
- 2018-03-01 CN CN201880028815.7A patent/CN110582206A/zh active Pending
- 2018-03-01 CA CA3054690A patent/CA3054690A1/en active Pending
- 2018-03-01 AU AU2018227544A patent/AU2018227544A1/en not_active Abandoned
-
2019
- 2019-08-26 IL IL26892919A patent/IL268929A/en unknown
- 2019-08-29 CO CONC2019/0009413A patent/CO2019009413A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
PE20200383A1 (es) | 2020-02-24 |
MX2019010370A (es) | 2019-10-22 |
EP3589129A4 (en) | 2020-11-25 |
IL268929A (en) | 2019-10-31 |
BR112019018088A2 (pt) | 2020-03-24 |
CO2019009413A2 (es) | 2019-09-09 |
EP3589129A1 (en) | 2020-01-08 |
AU2018227544A1 (en) | 2019-08-29 |
WO2018160827A1 (en) | 2018-09-07 |
CN110582206A (zh) | 2019-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210220323A1 (en) | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene or mineral | |
CA3054690A1 (en) | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes | |
CA2977802A1 (en) | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral | |
Gyesi et al. | Chemical composition, total phenolic content, and antioxidant activities of the essential oils of the leaves and fruit pulp of Annona muricata L.(Soursop) from Ghana | |
Bicas et al. | Volatile constituents of exotic fruits from Brazil | |
US11338222B2 (en) | Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons | |
Asikin et al. | The composition of volatile aroma components, flavanones, and polymethoxylated flavones in Shiikuwasha (Citrus depressa Hayata) peels of different cultivation lines | |
EP3261629A1 (en) | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral | |
Alighiri et al. | Study on the improvement of essential oil quality and its repellent activity of betel leaves oil (Piper betle l.) from Indonesia | |
WO2017100369A1 (en) | Printable cannabinoid and terpene compositions | |
Benkhoud et al. | Essential oils as flavoring and preservative agents: Impact on volatile profile, sensory attributes, and the oxidative stability of flavored extra virgin olive oil | |
Rowshan et al. | Changes of peel essential oil composition of Citrus aurantium L. during fruit maturation in Iran | |
Butnariu | Plants as source of essential oils and perfumery applications | |
Lis et al. | Comparison of chemical composition of the essential oils from different botanical organs of Pinus mugo growing in Poland | |
WO2019171170A1 (en) | Device and method for administering an active ingredient | |
del Refugio Ramos-Jerz | Phytochemical analysis of avocado seeds (Persea americana Mill., cv Hass) | |
US20240090545A1 (en) | Citrus modifier compounds in cannabis | |
Tomaszewski | Identification of the key aroma active compounds of propolis collected from central New Jersey over three consecutive years | |
US11602701B2 (en) | Method for extraction and isolation of cannabis terpene and aromatic isolates from cannabis sativa and cannabis indica | |
Andrade et al. | Volatile compounds from leaves and flowers of Garcinia macrophylla. | |
MIYA | PHYTOCHEMICAL STUDIES OF LEAVES AND PEELS OF LEMON AND THREE SPECIES OF GRAPE AND THEIR BIOLOGICAL ACTIVITIES | |
Marrellia et al. | NPC Natural Product Communications 2018 | |
Moreno-Chamba et al. | Aromatic and cannabinoid profiles of Cannabis inflorescences and seed oils: A comprehensive approach for variety characterization | |
WO2021179088A1 (en) | Terpene-enhanced compositions and uses thereof | |
Daluiso | An evaluation of sustainable sub-and supercritical fluid extraction technologies and traditional soxhlet for the isolation of high quality, natural Lavandula spp. Flavours |